Drug intelligence / Profile preview

Waid Cream

Development stage: Unknown
Lead developer: Medicos Service
Administration: Topical

Overview

Waid Cream is a topical botanical formulation developed by Medicos Service GmbH containing an extract of *Isatis tinctoria* (woad). It is designed as a body lotion to be applied twice daily for the treatment of xerosis cutis (dry skin) and pruritus (itchy/irritated skin). The extract is known for its anti-inflammatory, skin-softening, and moisturizing properties, which help soothe irritated skin and support the skin barrier. It has been investigated in a Phase II single-group clinical study in Germany to evaluate its caring and soothing effects in patients with dry and itchy skin conditions.

Brand names: Waid Cream
Other names: Woad CreamIsatis tinctoria extract cream

Beyond the preview

Go deeper on Waid Cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Waid Cream.

Explore the full profile